OpenCures
OpenCures operates a cloud-based platform that aggregates biomarker, wearable, and self-tracking data for proactive individuals, longevity clinics, and research organizations, paired with an exclusive metabolomics assay (ProdromeScan), biobanking services, and a 501c(3) nonprofit partner.
- Company typePrivate
- Founded2018
- HeadquartersNovato, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What OpenCures does
OpenCures (legally OpenOme Inc. DBA OpenCures) is a hybrid for-benefit biotechnology enterprise founded in 2018 by Kevin Perrott, PhD, and headquartered in Novato, California. The company operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, self-tracking inputs, and biobanked biospecimens into a unified personal health management system, paired with an exclusive arrangement to distribute Prodrome Sciences' research-grade metabolomics blood assay (ProdromeScan). It serves three primary segments: proactive individuals and biohackers seeking research-grade biomarker insights, longevity and functional medicine clinics using its client management SaaS, and research organizations running remote decentralized trials through its trial management module. A 501c(3) nonprofit partner (OpenCures Access) was established alongside the for-benefit entity to pursue mission-aligned research activities not directly profitable.
The platform's technical architecture centers on multiomic data categorization against reference databases, automated biomarker analytics with personalized functional ranges (including derived scores such as BMI, PhenoAge, and Framingham Risk Score), correlation and baseline detection on longitudinal inputs, AI-assisted supplement protocol planning, and a generic CSV/PDF data import engine. Complementary services include biobanking (subscription), blood draw logistics at the Novato office and via mobile phlebotomy (~$120 per session) nationwide in the US, and white-label platform deployment for partner clinics and laboratories. Compliance posture includes HIPAA Safe Harbor de-identification and self-attested GDPR handling, with data encrypted at rest for personally identifiable reports.
Revenue is generated through four streams: freemium-to-paid individual subscriptions with upsell to assays and biobanking; unit-priced research-grade assay sales with pay-as-you-go phlebotomy; annual tiered B2B SaaS subscriptions for longevity clinics; and enterprise subscriptions for research organizations plus white-label licensing fees. Distribution is predominantly direct-to-consumer through opencures.org and shop.opencures.org, with direct sales to mid-market clinics and research organizations and community-led referrals through longevity and biohacker networks. Named relationships include LongeCity (citizen science nonprofit), longevity clinics using the professional SaaS, research organizations running trials, and a coalition partnership within the Stanford-led THRIVE initiative backed by ARPA-H ($34.5M total program funding). The platform reports a 4.8/5 Trustpilot rating from over 2,000 reviews.
OpenCures firmographics
Firmographics- Name
- OpenCures
- Legal name
- OpenOme Inc.
- Website
- https://opencures.org
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- OpenCures operates a cloud-based platform that aggregates biomarker, wearable, and self-tracking data for proactive individuals, longevity clinics, and research organizations, paired with an exclusive metabolomics assay (ProdromeScan), biobanking services, and a 501c(3) nonprofit partner.
- Ownership category
- akta.pro rank
OpenCures industry classification
Industry- Product category
- Longevity Health Data Platform
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement) (HLACAIAL)
- akta.pro secondary industries
- eConsent & Digital Identity for Trials (HLACAOAE), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Governance, Risk & Compliance (GRC) + HIPAA/HITRUST/ISO Readiness (HLACAJAJ)
Keywords
Where OpenCures is headquartered
LocationHeadquarters
- HQ city
- Novato
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
OpenCures business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Platform SaaS Subscriptions: The for-benefit entity offers cloud-based software subscriptions to health professionals (longevity clinic client management) and research organizations (trial management). These are recurring revenue subscriptions with tiered feature access.
- ProdromeScan & Assay Services: OpenCures offers the ProdromeScan blood assay (metabolomics-based) and other blood panel tests directly to self-directed researchers and consumers. This is a one-time per-order revenue stream. Optional mobile phlebotomy service at ~$120 is available.
- Biobanking Services: Biospecimen storage service where participants can biobank remaining blood samples for future assay use, with ownership and access control retained by the individual. Revenue is generated per sample stored.
- White-label & Licensed Platform: OpenCures offers white-label versions of its platform to other longevity clinics, laboratories, and research organizations, embedding its technology into partner operations for a licensing fee.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | ProdromeScan assay — research-grade metabolomics blood test with results and interpretation workshop |
| Unit Pricing | Pay-as-you-go | Mobile phlebotomy add-on for remote blood draws |
| Freemium | Monthly | Platform for Individuals — personal health management dashboard with data integration and analytics |
| Subscription | Annual | Platform for Professionals — SaaS client management for longevity clinics |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
OpenCures product offering
Product offeringCore offering
OpenCures operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, and self-tracking inputs into a unified personal health management system. The company sells the research-grade ProdromeScan metabolomics blood assay, biobanking storage services, and dedicated SaaS modules for longevity clinics (client management) and research organizations (decentralized trial management). A hybrid for-benefit legal structure pairs the commercial entity (OpenOme Inc., DBA OpenCures) with a 501(c)(3) charity (OpenCures Access) to accelerate health technology development.
Product overview
OpenCures operates as a hybrid for-benefit enterprise offering a multi-product ecosystem centered on the OpenCures Platform (my.opencures.org), a web-based health data management system. The platform enables individuals to track biomarkers, integrate lab results and wearable data, and analyze health correlations. Complementary services include the ProdromeScan metabolomic assay (offered exclusively through OpenCures), biobanking for biospecimen storage, blood draw services (in-office and mobile phlebotomy), and dedicated modules for health professionals (client management) and researchers (trial management). An AI-assisted supplement planning feature personalizes wellness recommendations based on aggregated health data.
Differentiator
Problem solved
Functional benefit
Products and services
- OpenCures Platform A web-based health management platform at my.opencures.org that enables individuals to track health metrics, integrate lab results and wearable data, analyze longitudinal correlations, and participate in self-directed research with automated biomarker calculations.
- ProdromeScan A research-grade metabolomic blood test offered exclusively through OpenCures to self-directed researchers and consumers, providing comprehensive biomarker analysis with results automatically imported into the OpenCures Platform and accompanied by an interpretation workshop.
- Biobanking Service Frozen biospecimen storage service for blood samples with user-controlled ownership and access, enabling future testing as new assays or biological age clocks become available.
- Platform for Professionals A cloud-based client management system designed for longevity clinics, providing automated workflows, multi-source health data ingestion, automated reporting, and systematic holistic care delivery for client practices.
- Trial Management Platform A research platform enabling decentralized trial management with media-rich study landing pages, protocol builders, guided participant flows, automated notifications, consent collection, questionnaires, multi-source data collection, and access to biobanking and assays.
- Blood Draw Services Venous blood collection services available at the Novato, CA headquarters or via mobile phlebotomy (approximately $120 per session) nationwide in the US, required to obtain samples for the ProdromeScan assay and other tests.
- White-label Platform Licensing White-label deployments of the OpenCures platform offered to partner longevity clinics, laboratories, and research organizations, embedding the technology into partner operations for a licensing fee.
Quantifiable outcome
- Platform rated 4.8/5 on Trustpilot based on 2000+ reviews
- +1 more outcomes
Companies that use OpenCures
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
OpenCures technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature6 records
OpenCures partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core and minor.
- WHOOPcoreWHOOP joined the $34.5 million ARPA-H-backed THRIVE initiative led by Stanford, with OpenCures as a named coalition partner. WHOOP will contribute continuous physiological data from its wearable devices to the PROSPR IC score model, integrating with OpenCures' data infrastructure and research participant network. The coalition aims to develop an FDA-grade Intrinsic Capacity score predicting major health outcomes up to 20 years in advance.
- Stanford University (PROSPR)coreStanford's PROSPR (Population-based Imaging and Informatics) team leads the THRIVE initiative, developing the PROSPR Intrinsic Capacity (IC) score model. OpenCures participates as a data and platform partner in the coalition, contributing participant engagement and multiomic data aggregation capabilities.
- Buck Institute for Research on AgingcoreThe Buck Institute for Research on Aging is a coalition partner in the Stanford-led THRIVE initiative. OpenCures participates alongside the Buck Institute to contribute to the development of the IC score and translate it into accessible at-home assessments.
- Methuselah FoundationcoreMethuselah Foundation is a coalition partner in the ARPA-H-backed THRIVE initiative alongside OpenCures. The foundation has a long history supporting longevity science and is collaborating to accelerate translation of aging research into accessible health assessments.
- YMCAminorYMCA is a coalition partner in the Stanford-led THRIVE initiative. As a community organization with broad reach, YMCA contributes to the accessibility and translation of the IC score into community settings.
- Prodrome Sciences (ProdromeScan)coreOpenCures has an exclusive arrangement with ProdromeSciences to provide the ProdromeScan (research-grade metabolomics blood assay) to self-directed researchers. ProdromeSciences performs the analysis in San Diego, and OpenCures handles participant engagement, blood draw logistics, and result interpretation support.
- LongeCitycoreLongeCity collaborated with OpenCures to create a platform for the longevity community to share and analyze biomarker data. LongeCity's community of citizen scientists uses OpenCures' platform features for data management and research collaboration.
- Open LongevityminorOpen Longevity is listed as a partner organization on OpenCures' About page, collaborating within the integrated network of longevity clinics, research organizations, and biohacker communities.
- AgelessRXminorAgelessRX is listed as a partner organization, collaborating with OpenCures within the longevity ecosystem to accelerate access to health technologies.
- Rejuve.iominorRejuve.io is listed as a partner on OpenCures' About page, contributing to the integrated network approach to longevity research and health technology development.
- OpenCures Access (501c3)coreOpenCures partners with OpenCures Access, a 501c(3) nonprofit charity, to implement a multipronged strategy for accelerating health technology development. The nonprofit handles tasks that may not be directly profitable but are crucial for R&D, while the for-benefit entity handles commercially viable operations.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
OpenCures competitors and assessment
Company assessmentDirect peers
- Function Health: Direct-to-consumer blood-testing platform offering 100+ biomarker panels with longitudinal tracking and clinician review. Highly comparable to OpenCures' ProdromeScan + OpenCures Platform stack, targeting the same self-directed biohacker/health-conscious consumer.
- InsideTracker: Biomarker analysis platform that ingests blood, wearable, and DNA data and produces personalized health recommendations. Closely matches OpenCures' biomarker analytics, personalized functional ranges, and AI-assisted supplement planning capabilities.
- Viome: Consumer gut-microbiome and transcriptomic testing with AI-driven personalized nutrition recommendations. Same DTC-plus-data-platform-plus-AI-supplement model as OpenCures, and a direct competitor for self-directed longevity and wellness share of wallet.
- Tally Health: Biological-age testing and longevity-focused supplement regimens sold direct-to-consumer with longitudinal self-tracking. Targets the same longevity-conscious biohacker segment and operates with a similar precision-prevention positioning.
- Elysium Health: Longevity biotechnology company offering consumer-grade epigenetic biomarker products (e.g., Index) and supplements. Comparable in the consumer-longevity data + intervention offering that OpenCures is assembling through ProdromeScan and the platform.
- Levels Health: Continuous metabolic monitoring (CGM) software with biomarker aggregation and AI-driven recommendations. Comparable consumer health-data SaaS playbook, sharing OpenCures' emphasis on longitudinal data, integrations, and AI-assisted intervention planning.
Broad incumbents
- Thorne: Large supplement and health-testing brand with consumer lab-test offerings and practitioner channel. Overlaps with OpenCures' supplement-planning and biomarker analytics but operates at scale across multiple verticals rather than focusing on the longevity-research niche.
- Human Longevity Inc. Premium longevity concierge-medicine and whole-genome/imaging diagnostic platform. Pursues a similar 'proactive longevity data' thesis but at a high-touch clinic + diagnostics model rather than OpenCures' DTC + community-driven model.
- Fountain Life: Network of longevity/preventive-medicine clinics offering advanced diagnostics and AI-driven insights. Overlaps with OpenCures' longevity-clinic professional platform as both serve the same health-professional buyer with data-driven practice infrastructure.
Emerging players
- Mito Health: Early-stage longevity-focused biomarker tracking and health-coaching platform. Targeting a similar self-directed health-optimization audience with a smaller subscription-based offering, representing a possible fast-moving entrant in OpenCures' core segment.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
OpenCures social profiles
Digital presenceOpenCures compliance and trust
Trust signalCompliance2 records
OpenCures financial estimates
Financial estimateRevenue estimate
Valuation estimate
OpenCures leadership team
Management profileNumber of profiles
Profiles1 record
OpenCures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OpenCures M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OpenCures
What does OpenCures do?
OpenCures operates a cloud-based health data aggregation and analytics platform that ingests wearable data, lab results, and self-tracking inputs into a unified personal health management system. The company sells the research-grade ProdromeScan metabolomics blood assay, biobanking storage services, and dedicated SaaS modules for longevity clinics (client management) and research organizations (decentralized trial management). A hybrid for-benefit legal structure pairs the commercial entity (OpenOme Inc., DBA OpenCures) with a 501(c)(3) charity (OpenCures Access) to accelerate health technology development.
Is OpenCures a public or private company?
OpenCures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was OpenCures founded?
OpenCures was founded in 2018. It employs 1 to 10 people.
Where is OpenCures based?
OpenCures is headquartered in Novato, United States, in the North America region.
How does OpenCures make money?
Four revenue lines are on record. Platform SaaS Subscriptions are the primary driver. The others are prodromeScan & Assay Services, biobanking Services and white-label & Licensed Platform.
Who are OpenCures's main competitors?
Direct peers on record are Function Health, InsideTracker, Viome, Tally Health, Elysium Health and Levels Health. Broad incumbents are Thorne, Human Longevity Inc. and Fountain Life. Mito Health is listed as an emerging player.
Does OpenCures have an API?
No public API is recorded for OpenCures.
What industry is OpenCures in?
OpenCures's product category is Longevity Health Data Platform. Its primary akta.pro industry code is HLACAIAL, Data Access, Sharing & Marketplace Platforms (incl. TEFCA/QHIN enablement), with a secondary code of HLACAOAE, eConsent & Digital Identity for Trials. Its NAICS code is 5132 and its SIC code is 7372.